Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04958798 · ClinicalTrials.gov registry record · NA

Culturally Centering Medications for Opioid Use Disorder With American Indian and Alaska Native Communities

A NA study of Opioid Use Disorder, sponsored by New York State Psychiatric Institute.

Completed
Registry status
NA
Development phase
48
Enrollment target
3
Study locations

NCT04958798 is a NA study of Opioid Use Disorder that has completed, run by New York State Psychiatric Institute. The registered enrollment target is 48 participants, below the 4,656-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (99% lower). The trial reports 3 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04958798, a NA study of Opioid Use Disorder, has completed, sponsored by New York State Psychiatric Institute.

COMPLETED
Registry status
NA
Development phase
48 participants
Enrollment target
3
Study locations

Study Summary

This is a formative research study to test a culturally-centered, program-level implementation intervention to increase the use of medications for opioid use disorder in four healthcare and addiction specialty treatment sites serving American Indian and Alaska Native communities.

Conditions Studied

Interventions

  • BEHAVIORAL Culturally Centered MOUD Implementation Intervention

Study Locations (3)

Alaska

  • Southcentral Foundation - Anchorage

Minnesota

  • Native American Community Clinic - Minneapolis

South Dakota

  • Missouri Breaks - Eagle Butte

Trial Details

FieldValue
Enrollment Target 48 participants
Start Date 2021-12-20
Est. Completion 2025-01-16
Phase NA

What the Registry Record Tells You About NCT04958798

The ClinicalTrials.gov registry entry for NCT04958798 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,656-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (99% lower). The listed sponsor is New York State Psychiatric Institute, which has 364 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Opioid Use Disorder appearing as the primary indexed condition, and to 1 intervention - of which Culturally Centered MOUD Implementation Intervention is the first listed.

NCT04958798 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Alaska, Minnesota, South Dakota.

Frequently Asked Questions

What is clinical trial NCT04958798 about?

NCT04958798 is a clinical study titled "Culturally Centering Medications for Opioid Use Disorder With American Indian and Alaska Native Communities". This is a formative research study to test a culturally-centered, program-level implementation intervention to increase the use of medications for opioid use disorder in four healthcare and addiction specialty treatment sites serving American Indian and Alaska Native communities.

What is the current status of trial NCT04958798?

This trial is currently completed. It is a NA study. The enrollment target is 48 participants. The study started on 2021-12-20. Estimated completion is 2025-01-16.

What conditions does trial NCT04958798 study?

This clinical trial studies the following conditions: Opioid Use Disorder.

What interventions are being tested in trial NCT04958798?

The interventions under investigation include: Culturally Centered MOUD Implementation Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT04958798?

This trial is sponsored by New York State Psychiatric Institute, which has 364 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04958798 being conducted?

This trial has 3 study locations across Alaska, Minnesota, South Dakota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Opioid Use Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.